Proxi Biotech develops a bacteria-resistant vaccine to treat multi-drug-resistant bacterial infections.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Copenhagen
State: Hovedstaden
Zip:
Country: Denmark
Proxi Biotech develops a bacteria-resistant vaccine to treat multi-drug-resistant bacterial infections. Its BACTOVAC platform technology detoxifies bacterial toxins and kills multi-drug-resistant bacteria. It was founded in 2017 and is headquartered in Copenhagen, Denmark.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2019 | Convertible Note | 1 | - |
BioInnovation Institute BioInnovation Institute |
5/2019 | Convertible Note | 1 | - |
BioInnovation Institute BioInnovation Institute |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|